Sherzod Abdullaev

43 ta ish

Tashkent Pediatric Medical Institute

1. The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes

   Botir T. Daminov, PhD, ScD, Sherzod Abdullaev

   Maqola20133 iqtibos

   ABIABI:AkademIndex/2026.other.675663

2. SAT-334 DISPARITIES IN TRANSPLANTATION ACCESS ACROSS DIFFERENT COUNTRIES: AN ISN FELLOWS COLLABORATIVE STUDY

   Mahmoud E. Elrggal, Sibel Gökçay Bek, Elliot Koranteng Tannor +8

   MaqolaOAOchiq kirishOrgan Donation and TransplantationKidney International Reports20200 iqtibos

   ABIABI:AkademIndex/2020.article.002348

3. P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS

   Sherzod Abdullaev, Ranokhon Igamberdieva

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20200 iqtibos

   ABIABI:AkademIndex/2020.article.002654

4. P0317EARLY MARKERS OF RENAL INJURY AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME

   Sherzod Abdullaev

   MaqolaOAOchiq kirishHealthcare Systems and Public HealthNephrology Dialysis Transplantation20200 iqtibos

   ABIABI:AkademIndex/2020.article.002655

5. Epidemiological, clinical and morphological aspects of kidney damage in COVID-19

   Batir Daminov, Sherzod Abdullaev, Olimkhon Sharapov +1

   MaqolaOAOchiq kirishCOVID-19 Clinical Research StudiesJournal of Renal Injury Prevention20210 iqtibos

   ABIABI:AkademIndex/2021.article.001967

6. MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 iqtibos

   ABIABI:AkademIndex/2021.article.002955

7. POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION

   Ranokhon Igamberdieva, Sherzod Abdullaev, Olimkhon Sharapov

   MaqolaOAOchiq kirishNeurological Disorders and TreatmentsKidney International Reports20210 iqtibos

   ABIABI:AkademIndex/2021.article.004689

8. MO528INFLUENCE OF CARDIOVASCULAR DISEASES ON SURVIVAL RATES IN DIALYSIS PATIENTS IN A COHORT OF THE UZBEK POPULATION

   Olimkhon Sharapov, Sherzod Abdullaev

   MaqolaChronic Disease Management StrategiesNephrology Dialysis Transplantation20210 iqtibos

   ABIABI:AkademIndex/2021.article.005893

9. MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 iqtibos

   ABIABI:AkademIndex/2021.article.006221

10. MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/2022.article.002165

11. POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesKidney International Reports20220 iqtibos

    ABIABI:AkademIndex/2022.article.002924

12. POS-592 COMPARATIVE ANALYSIS OF THE CAUSES OF DEATH IN DIALYSIS PATIENTS WITH AND WITHOUT CARDIOVASCULAR DISEASES

    Olimkhon Sharapov, Botir Daminov, Sherzod Abdullaev

    MaqolaOAOchiq kirishBlood Pressure and Hypertension StudiesKidney International Reports20220 iqtibos

    ABIABI:AkademIndex/2022.article.002955

13. POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesKidney International Reports20220 iqtibos

    ABIABI:AkademIndex/2022.article.002970

14. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/2022.article.004913

15. MO634: Effects of Dapagliflozin in Patients with Heart Failure

    Sherzod Abdullaev, Olimkhon Sharapov

    MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/2022.article.004922

16. MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/2022.article.004975

17. MO143: Dynamics of Renal Function during Anticoagulant Therapy in Stage 4 CKD and AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/2022.article.004978

18. Oral anticoagulation in end-stage CKD and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesInternational Journal of Health Sciences20220 iqtibos

    ABIABI:AkademIndex/2022.article.007035

19. Awareness of chronic kidney disease and its risk factors in the former Soviet Union countries

    Alimzhan Muxunov, N. Bulanov, Sultan Makhmetov +9

    MaqolaOAOchiq kirishBlood Pressure and Hypertension StudiesElectronic Journal of General Medicine20230 iqtibos

    ABIABI:AkademIndex/2023.article.002007

20. #3055 ASSOCIATION OF MORTALITY WITH INTRADIALYTIC EXERCISE IN HEMODIALYSIS PATIENTS

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaOAOchiq kirishDialysis and Renal Disease ManagementNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.002567

21. #3896 SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.003120

22. #3440 TOCILIZUMAB INDUCTION THERAPY IN KIDNEY TRANSPLANTATION

    Sherzod Abdullaev, Olimkhon Sharapov

    MaqolaOAOchiq kirishRenal Transplantation Outcomes and TreatmentsNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.003791

23. #4691 LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

    Olimkhon Sharapov, Sherzod Abdullaev

    MaqolaOAOchiq kirishGenetic and Kidney Cyst DiseasesNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.008408

24. #2765 EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD

    Sherzod Abdullaev, Olimkhon Sharapov, Ranokhon Igamberdieva

    MaqolaOAOchiq kirishSARS-CoV-2 and COVID-19 ResearchNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.008409

25. #3015 EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD

    Sherzod Abdullaev, Olimkhon Sharapov

    MaqolaOAOchiq kirishDiabetes Treatment and ManagementNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.008410